Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.
Press releases published on August 6, 2025

Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress
Strong execution of two ongoing Phase 3 trials of daraxonrasib; for RASolute 302, company is winding down enrollment in U.S. and expects to complete enrollment of the trial this year FDA Breakthrough Therapy Designations granted for two RAS(ON) inhibitors …

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Keros Therapeutics Reports Second Quarter 2025 Financial Results
LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of …

Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
Topline data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for year-end 2025 readouts Aleniglipron clinical development program expanded to optimize competitive positioning and Phase 3 program Oral small …

Fredonia Mining Inc. Grants Stock Options
TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fredonia Mining Inc. (“Fredonia” or the “Company”) (TSXV: FRED) has granted a total of 985,000 stock options (the “Options”) of the Company to purchase a total of 985,000 common shares at a price of $0.40 per …

Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) announces that the Supreme Court of British Columbia today has dismissed the application of the Xatśūll First Nation (“ …

Highlands Realty and Sea Glass Announce Strategic Co-Branding Partnership to Expand Presence in Southwest Virginia
Sea Glass and Highlands Realty announce a strategic partnership to expand services and deliver enhanced support, technology, and reach across the region. ABINGDON, VA, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Sea Glass, a boutique real estate …

Gate Joins Global Dollar Network as a First-Tier Partner, Leading Stablecoin Adoption
PANAMA CITY, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Gate, a leading global crypto exchange, announced its official participation in Global Dollar Network (GDN), an open network designed to accelerate stablecoin adoption worldwide. Gate has integrated support …

₿itopia by Bitget Turns Heartbeats into Art at UNTOLD Romania
CLUJ‑NAPOCA, Romania, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's leading cryptocurrency exchange and Web3 company, unveils ₿itopia: #FeelThe₿eat, Interactive 360° Digital installation at UNTOLD X Festival in Romania from August 7–11. This …

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today that it has entered into a securities purchase agreement with a U. …

Dundee Precious Metals Announces Satisfaction of Bosnian Competition Council Condition for Acquisition of Adriatic Metals
TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM”) is pleased to report that the condition to the proposed acquisition by DPM of Adriatic Metals plc (“Adriatic”), previously announced on June 13, 2025 (the “ …

Inter&Co Reaches 40 Million Clients with 53% Net Income Growth and Robust Credit Expansion in 2Q25
MIAMI, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Inter…

AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)
There will be presentations on the latest positive progress from AIM’s clinical program in pancreatic cancer, the positive therapeutic effects of AIM’s drug Ampligen on multiple cancer types, and Ampligen’s mechanism of action in oncology Discussion will …

Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update
Conference Call and Webcast Scheduled for August 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the …

Veru Announces Reverse Stock Split
MIAMI, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that it will …

RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are currently purchasing and have made repeat orders of …

Ozak AI Hits Major Milestone With $1.5M+ Raised—What’s Next?
ROAD TOWN, British Virgin Islands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Ozak AI has officially raised over $1.5 million in its presale, capturing the attention of retail and institutional investors alike. With the presale currently in Stage 4 and the token …

Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …

DAM Fashion by Deborah Ann Mack Announces Re-Grand Opening and Fall 2025 Coat Preview
DAM Fashion celebrates one year in its expanded West Chester location with a ribbon-cutting and preview of its Fall 2025 custom coat collection. WEST CHESTER, PA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- DAM Fashion, a couture boutique …

PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results
PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …